Clinical Trial Update: ONDANSETRON AND EFFECTIVE DOSE IN 50% OF SUBJECTS OF PROPHYLACTIC NOREPINEPHRINE INFUSIONS FOR PREVENTING SPINAL ANESTHESIA-INDUCED HYPOTENSION DURING CESAREAN DELIVERY [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial exploring the effective dose of ondansetron to prevent spinal anesthesia–induced hypotension during cesarean delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Delivery
• Hypotension
• Spinal Anesthesia-induced Hypotension

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Laval University | Conditions: Hypotension, Anesthesia; Adverse Effect, Spinal and Epidural | Phase 3 | Status: UNKNOWN